461 related articles for article (PubMed ID: 18625168)
41. Dutasteride significantly improves quality of life measures in patients with enlarged prostate.
O'Leary MP; Roehrborn CG; Black L
Prostate Cancer Prostatic Dis; 2008; 11(2):129-33. PubMed ID: 17592479
[TBL] [Abstract][Full Text] [Related]
42. [Lower urinary tract symptoms are poorly correlated with erectile dysfunction].
Marionneau N; Perrin P; Taieb C
Prog Urol; 2006 Nov; 16(5):572-7. PubMed ID: 17175954
[TBL] [Abstract][Full Text] [Related]
43. [Symptom scores: what do they describe exactly?].
Pupca G; Patard JJ; Ziadé J; Guiraud P; Lobel B; Guillé F
Prog Urol; 2000 Sep; 10(4):561-7. PubMed ID: 11064897
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia.
Barry MJ
Urology; 2001 Dec; 58(6 Suppl 1):25-32; discussion 32. PubMed ID: 11750246
[TBL] [Abstract][Full Text] [Related]
45. Should patients with symptomatic BPH have a trial of medical therapy by their general practitioner prior to referral for urological assessment?
McGuire BB; O'Brien MF; McLoughlin S; O'Malley KJ; Fitzpatrick JM
Ir Med J; 2007 Apr; 100(4):428-9. PubMed ID: 17566476
[TBL] [Abstract][Full Text] [Related]
46. Managing prostate disorders in middle age and beyond.
Loughlin KR; Whitmore WF
Geriatrics; 1987 Jul; 42(7):45-52, 55-6. PubMed ID: 2439409
[TBL] [Abstract][Full Text] [Related]
47. [Review of 408 cases of prostatism syndrome. Have the new classifications improved its practical management?].
Fernández Gómez JM; Rabade Rey CJ; Pérez García FJ; Sahagun Argüello JL; García Menéndez T; Alonso Sainz F
Actas Urol Esp; 1996; 20(7):614-23. PubMed ID: 8975546
[TBL] [Abstract][Full Text] [Related]
48. Benign prostatic hyperplasia in primary care: what you need to know.
Burnett AL; Wein AJ
J Urol; 2006 Mar; 175(3 Pt 2):S19-24. PubMed ID: 16458735
[TBL] [Abstract][Full Text] [Related]
49. Alpha-adrenergic receptor antagonists in older patients with benign prostatic hyperplasia: issues and potential complications.
Fine SR; Ginsberg P
J Am Osteopath Assoc; 2008 Jul; 108(7):333-7. PubMed ID: 18648026
[TBL] [Abstract][Full Text] [Related]
50. [Development and validation of a quality of life scale associated with health status, specific for benign hypertrophy of the prostate and including a sexuality evaluation scale].
Lukacs B; McCarthy C; Leplege A; Comet D
Prog Urol; 1994 Oct; 4(5):688-99. PubMed ID: 7532071
[TBL] [Abstract][Full Text] [Related]
51. [The international system of overall scoring assessment of the symptoms and quality of life of patients with benign prostatic hyperplasia].
Trapeznikova MF; Bazaev VV; Golubev GV; Mezentsev VA
Urol Nefrol (Mosk); 1996; (2):2-4. PubMed ID: 8677545
[TBL] [Abstract][Full Text] [Related]
52. [Administration of afala preparation in urological practice].
Neĭmark AI; Isaenko VI; Iakovets IaV; Simashkevich AV; Aliev RT
Urologiia; 2009; (3):67-70. PubMed ID: 19673125
[TBL] [Abstract][Full Text] [Related]
53. Enlarged prostate: a landmark national survey of its prevalence and impact on US men and their partners.
Roehrborn CG; Marks L; Harkaway R
Prostate Cancer Prostatic Dis; 2006; 9(1):30-4. PubMed ID: 16231014
[TBL] [Abstract][Full Text] [Related]
54. Facilitating the medical management of benign prostatic hyperplasia in primary care.
Rees J
BJU Int; 2010 Jan; 105(1):131-2. PubMed ID: 20132105
[No Abstract] [Full Text] [Related]
55. Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.
Barry MJ; Williford WO; Fowler FJ; Jones KM; Lepor H
J Urol; 2000 Nov; 164(5):1559-64. PubMed ID: 11025704
[TBL] [Abstract][Full Text] [Related]
56. Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self.
Cam K; Akman Y; Cicekci B; Senel F; Erol A
Prostate Cancer Prostatic Dis; 2004; 7(1):41-4. PubMed ID: 14999237
[TBL] [Abstract][Full Text] [Related]
57. Cultural and linguistic validation of questionnaires for use in international studies: the nine-item BPH-specific quality-of-life scale.
Boyle P
Eur Urol; 1997; 32 Suppl 2():50-2. PubMed ID: 9248816
[TBL] [Abstract][Full Text] [Related]
58. When to investigate benign prostatic hyperplasia.
Thomas D
Practitioner; 1997 Jul; 241(1576):408-13. PubMed ID: 9425714
[No Abstract] [Full Text] [Related]
59. The role of the general practitioner in the diagnosis and treatment of benign prostatic hyperplasia (BPH).
Janknegt RA; Roehrborn CG
Prog Clin Biol Res; 1994; 386():313-29. PubMed ID: 7528400
[No Abstract] [Full Text] [Related]
60. Managing patients with benign prostatic hyperplasia.
Hicks RJ; Cook JB
Am Fam Physician; 1995 Jul; 52(1):135-42, 145-6. PubMed ID: 7541601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
